Extended treatment of locally advanced or metastatic non-small cell lung cancer with bevacizumab.
Journal Title: Pulmonologija ir alergologija - Year 2017, Vol 1, Issue 1
Abstract
Bevacizumab for extended treatment of locally advanced or metastatic non-small cell lung cancer. Pros and cons.
Authors and Affiliations
Virginija Kalinauskaitė-Žukauskė
Keywords
Related Articles
- EP ID EP266214
- DOI -
- Views 92
- Downloads 0
Eosinophil induced airway smooth muscle remodelling in asthma
Characteristics of the studied subjects: A total of 39 nonsmoking adults participated in the study (22 steroid-free patients with intermittent or mild-to moderate persistent asthma, and 17 healthy participants who consti...
FLUTICASONE FUROATE/VILANTEROL 92/22 ΜG ONCEADAY VS BECLOMETHASONE DIPROPIONATE/FORMOTEROL 100/6 ΜG B.I.D. IN ASTHMA PATIENTS: A 12WEEK PILOT STUDY
A 12-week pilot study was conducted to compare once-daily Fluticasone/Vilanterol 92/22 μg combination with twice daily Beclomethasone/Formoterol 100/6 μg association in moderate asthma, in terms of quality o...
RECOMMENDATIONS FOR DIAGNOSIS AND MANAGEMENT OF IDIOPATHIC PULMONARY FIBROSIS 2017
Idiopathic pulmonary fibrosis (IPF) IPF is a specific form of chronic, progressive fibrosing interstitial pneumonia of unknown cause occurring in adults. The incidence has been rising in recent years probably due to impr...
EFFICACY OF OMALIZUMAB TREATMENT FOR PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
Background. Chronic spontaneous urticaria is defined as itchy hives, lasting for 6 and more weeks, with or without angioedema. Part of the patients do not have a response to a standard therapy with H1 antihistamines even...
Lithuanian guidelines on evaluation and treatment of severe asthma in adults, 2017.
Lithuanian guidelines on evaluation and treatment of severe asthma in adults, 2017.